PortfoliosLab logo
TRML vs. TRAK
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between TRML and TRAK is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

TRML vs. TRAK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tourmaline Bio Inc. (TRML) and Park City Group Inc (TRAK). The values are adjusted to include any dividend payments, if applicable.

-100.00%0.00%100.00%200.00%300.00%400.00%December2025FebruaryMarchAprilMay
-79.08%
351.03%
TRML
TRAK

Key characteristics

Sharpe Ratio

TRML:

-0.06

TRAK:

0.89

Sortino Ratio

TRML:

0.40

TRAK:

1.50

Omega Ratio

TRML:

1.04

TRAK:

1.18

Calmar Ratio

TRML:

-0.05

TRAK:

1.33

Martin Ratio

TRML:

-0.14

TRAK:

3.30

Ulcer Index

TRML:

29.87%

TRAK:

11.16%

Daily Std Dev

TRML:

67.87%

TRAK:

38.20%

Max Drawdown

TRML:

-94.97%

TRAK:

-96.87%

Current Drawdown

TRML:

-81.73%

TRAK:

-11.20%

Fundamentals

Market Cap

TRML:

$418.72M

TRAK:

$401.43M

EPS

TRML:

-$2.89

TRAK:

$0.32

PS Ratio

TRML:

0.00

TRAK:

18.94

PB Ratio

TRML:

1.47

TRAK:

8.21

Total Revenue (TTM)

TRML:

$40.00K

TRAK:

$16.11M

Gross Profit (TTM)

TRML:

$10.00K

TRAK:

$13.41M

EBITDA (TTM)

TRML:

-$98.47M

TRAK:

$6.15M

Returns By Period

In the year-to-date period, TRML achieves a -25.54% return, which is significantly lower than TRAK's -0.77% return.


TRML

YTD

-25.54%

1M

21.04%

6M

-47.50%

1Y

-4.25%

5Y*

N/A

10Y*

N/A

TRAK

YTD

-0.77%

1M

10.98%

6M

4.01%

1Y

33.71%

5Y*

32.31%

10Y*

7.51%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

TRML vs. TRAK — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TRML
The Risk-Adjusted Performance Rank of TRML is 4848
Overall Rank
The Sharpe Ratio Rank of TRML is 4949
Sharpe Ratio Rank
The Sortino Ratio Rank of TRML is 4949
Sortino Ratio Rank
The Omega Ratio Rank of TRML is 4747
Omega Ratio Rank
The Calmar Ratio Rank of TRML is 4848
Calmar Ratio Rank
The Martin Ratio Rank of TRML is 4848
Martin Ratio Rank

TRAK
The Risk-Adjusted Performance Rank of TRAK is 8181
Overall Rank
The Sharpe Ratio Rank of TRAK is 8282
Sharpe Ratio Rank
The Sortino Ratio Rank of TRAK is 7878
Sortino Ratio Rank
The Omega Ratio Rank of TRAK is 7474
Omega Ratio Rank
The Calmar Ratio Rank of TRAK is 8888
Calmar Ratio Rank
The Martin Ratio Rank of TRAK is 8181
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TRML vs. TRAK - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Tourmaline Bio Inc. (TRML) and Park City Group Inc (TRAK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current TRML Sharpe Ratio is -0.06, which is lower than the TRAK Sharpe Ratio of 0.89. The chart below compares the historical Sharpe Ratios of TRML and TRAK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00December2025FebruaryMarchAprilMay
-0.06
0.89
TRML
TRAK

Dividends

TRML vs. TRAK - Dividend Comparison

TRML has not paid dividends to shareholders, while TRAK's dividend yield for the trailing twelve months is around 0.32%.


TTM202420232022
TRML
Tourmaline Bio Inc.
0.00%0.00%57.75%0.00%
TRAK
Park City Group Inc
0.32%0.31%0.76%0.30%

Drawdowns

TRML vs. TRAK - Drawdown Comparison

The maximum TRML drawdown since its inception was -94.97%, roughly equal to the maximum TRAK drawdown of -96.87%. Use the drawdown chart below to compare losses from any high point for TRML and TRAK. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-81.73%
-11.20%
TRML
TRAK

Volatility

TRML vs. TRAK - Volatility Comparison

Tourmaline Bio Inc. (TRML) has a higher volatility of 24.74% compared to Park City Group Inc (TRAK) at 7.72%. This indicates that TRML's price experiences larger fluctuations and is considered to be riskier than TRAK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%December2025FebruaryMarchAprilMay
24.74%
7.72%
TRML
TRAK

Financials

TRML vs. TRAK - Financials Comparison

This section allows you to compare key financial metrics between Tourmaline Bio Inc. and Park City Group Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00M2.00M3.00M4.00M5.00M6.00M202120222023202420250
5.49M
(TRML) Total Revenue
(TRAK) Total Revenue
Values in USD except per share items